A pharmaceutical company just bet big on crypto. Rain (RAIN) spiked 7% after immunotherapy firm Enlivex announced a $21 million debt financing deal tied directly to the prediction market crypto token.
Enlivex, which develops cell therapy for knee osteoarthritis, exercised an option to acquire 3 billion RAIN tokens at a 62% discount for $10 million, while extending its option to purchase another 272.1 billion RAIN tokens at the same discounted price through December 2027. The $21 million in debt financing came from New York-based asset manager The Lind Partners.
“We are continuing to execute our prediction markets treasury strategy,” said Enlivex executive chair Shai Novik.
The company also approved a $20 million share buyback program alongside the announcement, a signal it is managing both sides of its balance sheet simultaneously.
Enlivex joins a growing list of non-crypto companies treating digital assets as a treasury strategy, following the well-documented playbook of firms like Gamestop. But with RAIN already pulling back after its initial pop, can retail momentum follow institutional conviction?
DISCOVER: 15+ Upcoming Coinbase Listings to Watch in 2025
Can RAIN Crypto Hit $0.0093 Again After the Enlivex Bounce?
RAIN is currently trading near $0.0071, representing the 7% spike that followed Enlivex’s announcement. The token reached an all-time high of $0.0109 following its KuCoin listing announcement in early January 2026, and that level now serves as meaningful near-term resistance.
Technically, the picture is mixed. RSI sits at 37, neutral but leaning toward oversold territory, while the 50-MA sits below the 200-MA, a formation that typically signals caution. Key support lies in the $0.0069 range; a close below that zone would invalidate any short-term bullish thesis. Resistance clusters near $0.009619, with short-term forecasts targeting $0.009110.
The 24-hour volume of $23.6 million shows genuine interest, and this is not a ghost rally. Whether that interest compounds or evaporates depends on whether RAIN can close above $0.009 on meaningful volume.
DISCOVER: 10+ Next Crypto to 100X In 2025
LiquidChain Targets Early-Mover Upside as RAIN Tests Key Resistance
RAIN’s 62% discount deal for Enlivex underscores an uncomfortable reality for retail investors: the best prices in crypto often go to those with institutional access, negotiating power, or early-stage timing. By the time a token is listed on KuCoin and trading near its ATH, the asymmetric upside has already shifted hands.
LiquidChain ($LIQUID) is currently in presale at $0.01447, with $640K raised so far. It is positioning itself as a Layer 3 infrastructure play. A cross-chain liquidity layer that fuses Bitcoin, Ethereum, and Solana liquidity into a single execution environment.
The next layer starts here. 👁⟁https://t.co/vqvBcdSQYC pic.twitter.com/vBzPngPk2e
— LiquidChain (@getliquidchain) April 6, 2026
The core pitch for developers is a Deploy-Once Architecture: build once, access all three ecosystems simultaneously, with Verifiable Settlement and a Unified Liquidity Layer handling the complexity underneath. That kind of cross-chain interoperability is exactly what the fragmented 2026 market is hungry for.
For investors watching RAIN trade near its ATH while insiders bought at a 62% discount, LiquidChain’s presale pricing at least offers the kind of entry point that institutional players typically reserve for themselves.
Do your own research. The presale milestone momentum is worth tracking.
DISCOVER: Top Crypto Presales to Watch Now
Follow 99Bitcoins on X (Twitter) For the Latest Market Updates and Subscribe on YouTube For Daily Expert Market Analysis.
Why you can trust 99Bitcoins
Established in 2013, 99Bitcoin’s team members have been crypto experts since Bitcoin’s Early days.
Weekly Research
100k+Monthly readers
Expert contributors
2000+Crypto Projects Reviewed
